Can these drugs stop eye cancer in its tracks?
NCT ID NCT02068586
First seen Mar 22, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This study tests two drugs, sunitinib and valproic acid, in people with high-risk uveal melanoma (a type of eye cancer) that has been treated but is likely to spread. The goal is to see if either drug can prevent the cancer from coming back or spreading to other parts of the body. About 210 participants will take one of the drugs for a period of time and be followed for survival and relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRIS MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.